These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9007055

  • 1. Plasmas from lymphocyte- and macrophage-tropic SIVmac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures.
    Zhuge W, Jia F, Adany I, Narayan O, Stephens EB.
    Virology; 1997 Jan 06; 227(1):24-33. PubMed ID: 9007055
    [Abstract] [Full Text] [Related]

  • 2. Neutralization/enhancement of macrophage-tropic SIVmac infection by plasma from macaques infected with macrophage-tropic or lymphocyte-tropic SIVmac.
    Jolly PE, Huang L, Chen S.
    Cell Mol Biol (Noisy-le-grand); 2001 Sep 06; 47(6):997-1008. PubMed ID: 11785666
    [Abstract] [Full Text] [Related]

  • 3. Failure of SIVmac to be neutralized in macrophage cultures is unique to SIVmac and not observed with neutralization of SHIV or HIV-1.
    Zhuge W, Jia F, Stephens EB, Li Z, Wang C, Joag SV, Narayan O.
    AIDS Res Hum Retroviruses; 1998 Aug 10; 14(12):1045-51. PubMed ID: 9718119
    [Abstract] [Full Text] [Related]

  • 4. Emergence of antigenic variants of simian immunodeficiency virus (SIVmac) in a seronegative macaque after SIVmac239 infection.
    Chuang LF, Blackbourn DJ, Chuang AJ, Killam KF, Liu X, Li Y, Kung HF, Chuang RY.
    Cell Mol Biol Res; 1994 Aug 10; 40(7-8):661-9. PubMed ID: 7787884
    [Abstract] [Full Text] [Related]

  • 5. Antibodies that neutralize SIV(mac)251 in T lymphocytes cause interruption of the viral life cycle in macrophages by preventing nuclear import of viral DNA.
    Zhuge W, Jia F, Mackay G, Kumar A, Narayan O.
    Virology; 2001 Sep 01; 287(2):436-45. PubMed ID: 11531420
    [Abstract] [Full Text] [Related]

  • 6. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC.
    Vaccine; 2006 Mar 10; 24(11):1811-20. PubMed ID: 16274888
    [Abstract] [Full Text] [Related]

  • 7. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z, Gettie A, Ho DD, Marx PA.
    Virology; 1998 Jun 20; 246(1):113-24. PubMed ID: 9656999
    [Abstract] [Full Text] [Related]

  • 8. Antigenic variation of molecularly cloned SIVmac239 during persistent infection in a rhesus macaque.
    Joag SV, Anderson MG, Clements JE, McEntee MF, Sharma DP, Adams RJ, Narayan O.
    Virology; 1993 Aug 20; 195(2):406-12. PubMed ID: 8337820
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
    Chackerian B, Haigwood NL, Overbaugh J.
    Virology; 1995 Nov 10; 213(2):386-94. PubMed ID: 7491763
    [Abstract] [Full Text] [Related]

  • 10. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
    Jaspan HB, Robinson JE, Amedee AM, Van Dyke RB, Garry RF.
    J Clin Virol; 2004 Nov 10; 31(3):190-7. PubMed ID: 15465411
    [Abstract] [Full Text] [Related]

  • 11. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ, Villinger F, Pinson D, Hou Y, Adany I, Li Z, Dalal R, Raghavan R, Kumar A, Narayan O.
    Virology; 2002 Mar 30; 295(1):54-62. PubMed ID: 12033765
    [Abstract] [Full Text] [Related]

  • 12. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
    Means RE, Matthews T, Hoxie JA, Malim MH, Kodama T, Desrosiers RC.
    J Virol; 2001 Apr 30; 75(8):3903-15. PubMed ID: 11264379
    [Abstract] [Full Text] [Related]

  • 13. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus.
    Marthas ML, Banapour B, Sutjipto S, Siegel ME, Marx PA, Gardner MB, Pedersen NC, Luciw PA.
    J Med Primatol; 1989 Apr 30; 18(3-4):311-9. PubMed ID: 2547965
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
    Kumar A, Lifson JD, Silverstein PS, Jia F, Sheffer D, Li Z, Narayan O.
    Virology; 2000 Aug 15; 274(1):149-64. PubMed ID: 10936096
    [Abstract] [Full Text] [Related]

  • 15. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.
    Liu ZQ, Muhkerjee S, Sahni M, McCormick-Davis C, Leung K, Li Z, Gattone VH, Tian C, Doms RW, Hoffman TL, Raghavan R, Narayan O, Stephens EB.
    Virology; 1999 Aug 01; 260(2):295-307. PubMed ID: 10417264
    [Abstract] [Full Text] [Related]

  • 16. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O.
    Virology; 2001 Jan 05; 279(1):241-56. PubMed ID: 11145906
    [Abstract] [Full Text] [Related]

  • 17. The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.
    Igarashi T, Imamichi H, Brown CR, Hirsch VM, Martin MA.
    J Leukoc Biol; 2003 Nov 05; 74(5):772-80. PubMed ID: 14595005
    [Abstract] [Full Text] [Related]

  • 18. Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus.
    Stahl-Hennig C, Voss G, Dittmer U, Coulibaly C, Petry H, Makoschey B, Cranage MP, Aubertin AM, Lüke W, Hunsmann G.
    AIDS; 1993 Jun 05; 7(6):787-95. PubMed ID: 8363756
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus.
    Bergmeier LA, Walker J, Tao L, Cranage M, Lehner T.
    Immunology; 1994 Oct 05; 83(2):213-20. PubMed ID: 7835937
    [Abstract] [Full Text] [Related]

  • 20. Differences in neutralization of simian lentivirus (SIVMAC) in lymphocyte and macrophage cultures.
    McEntee MF, Anderson MG, Daniel MD, Adams R, Farzadegan H, Desrosiers RC, Narayan O.
    AIDS Res Hum Retroviruses; 1992 Jun 05; 8(6):1193-8. PubMed ID: 1503828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.